ALB and hepatocellular carcinoma: Irrespective of the thresholds considered, we acknowledge that FIB-4/APRI-based algorithms may not be the best method to stratify the HCC risk in cirrhotic patients achieving SVR; we have recently compared [43] different non-invasive scoring systems (the Forns index, FIB-4, albumin-bilirubin score [ALBI], age/gender/albumin-bilirubin/platelets score [aMAP]) in cirrhotics successfully treated by DAAs, and we found that ALBI showed the highest diagnostic accuracy for the detection of HCC, confirming previous data [44,45,46].